Unique ID issued by UMIN | UMIN000014642 |
---|---|
Receipt number | R000017034 |
Scientific Title | Study of combination therapy with endoscopic triamsinolone injection and polyglycolic acid sheet for the prevention of esophageal stricture after endoscopic submucosal dissection |
Date of disclosure of the study information | 2014/07/25 |
Last modified on | 2016/01/29 19:11:20 |
Study of combination therapy with endoscopic triamsinolone injection and polyglycolic acid sheet for the prevention of esophageal stricture after endoscopic submucosal dissection
Study of combination therapy with endoscopic triamsinolone injection and polyglycolic acid sheet for the prevention of esophageal stricture after endoscopic submucosal dissection
Study of combination therapy with endoscopic triamsinolone injection and polyglycolic acid sheet for the prevention of esophageal stricture after endoscopic submucosal dissection
Study of combination therapy with endoscopic triamsinolone injection and polyglycolic acid sheet for the prevention of esophageal stricture after endoscopic submucosal dissection
Japan |
esophageal cancer
Gastroenterology |
Malignancy
NO
To evaluate the safety and efficacy of combination therapy with endoscopic triamsinolone injection and polyglycolic acid sheetfor the prevention of esophageal stricture after endoscopic submucosal dissection
Efficacy
Rate of esophageal stricture
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine |
Combination therapy with endoscopic triamsinolone injection and polyglycolic acid sheet
20 | years-old | <= |
Not applicable |
Male and Female
Patient who will be performed endoscopic treatment for esophageal cancer. Absolute or relative indication of endoscopic treatment within the therapy guidelines for esophageal cancer.
ESD is planned for esophageal cancer, and expected to result of a size of more than 1/2 luminal circumferencial esophageal cancer.
ECOG Performance status 0-2.
Aged upper 20 years old.
Written informed consent.
Active infection.
Patients with continuous systemic steroids medication.
Psychosis. Patients who have been judged as inappropriate for this study.
14
1st name | |
Middle name | |
Last name | Hisashi Doyama |
Ishikawa prefectural central hospital
Department of Gastroenterology
2-1 Kuratukihigashi Kanazawa-shi Ishikawa-ken
076-237-8211
doyama.134@ipch.jp
1st name | |
Middle name | |
Last name | Kunihiro Tsuji |
Ishikawa prefectural central hospital
Department of Gastroenterology
2-1 Kuratukihigashi Kanazawa-shi Ishikawa-ken
076-237-8211
m92162g@ipch.jp
Ishikawa prefectural central hospital
None
Self funding
NO
2014 | Year | 07 | Month | 25 | Day |
Unpublished
Terminated
2014 | Year | 06 | Month | 01 | Day |
2014 | Year | 07 | Month | 25 | Day |
2014 | Year | 07 | Month | 24 | Day |
2016 | Year | 01 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017034
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |